期刊文献+

贝那普利对高血压病患者肾脏保护作用研究进展 被引量:5

下载PDF
导出
摘要 原发性高血压(essential hypertension,EH)是以血压升高为主要临床表现的综合征。通常简称为高血压病,高血压病是多种心、脑、肾疾病的重要病因及危险因素,严重影响靶器官的结构及功能,最终导致这些器官功能衰竭。作为影响人类健康的重要疾病,尽管医学界在治疗高血压道路上不断探索前进,治疗药物和手段不断发展,但全球高血压控制状况却不容乐观。目前其患病率仍在不断上升。
出处 《河北医药》 CAS 2013年第5期755-756,共2页 Hebei Medical Journal
  • 相关文献

参考文献25

  • 1刘丽,王文.高血压前期的临床研究进展[J].中华高血压杂志,2006,14(11):867-869. 被引量:24
  • 2Quieshi AI, Suri MF, Kirmani JF, et al. Prevalence and trends of prehy- pertension and hypertension in United States:National Health and Nutri- tion Examination Surveys 1976 to 2000. Med Sci Monit, 2005, 11: CR403-409.
  • 3Ramos E ,Barros H. Pervalence of hypertension in 13-year-old dolescents in Potro, Portugal. Rev Port Cardiol,2005,24:1075-1087.
  • 4Wang Y, Wang QJ, The prevalenee of prehypertension and hypertensionamong US adults according to the new Joint National Committee uide- lines. Areh Intern Med,2004,164:2126-2134.
  • 5赵晶,王久惠,魏宗德.血压变异性与高血压病早期肾损害的相关性研究[J].西部医学,2008,20(1):65-67. 被引量:22
  • 6Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of pro- gression to hypertension in non-hypertensive participants in the Framing- ham Heart Study:a cohort study. Lancet,2001,358:1682-1686.
  • 7Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for eveloping hypertension in middle-aged women and men:The Framingham Heart Study. JAMA ,2002,287 : 1003-1010.
  • 8Crysohoou C, Pitsavos C, Panagiotakos DB, et al. Association between prehypertension status and inflammatory markers related to athero sclerot- ic disease : the AIq'ICA study. Am J Hypertens ,2004,17:568-573.
  • 9黄振文,张菲斐主编.高血压.第1版.上海交通大学出版社,2010.105-107.
  • 10王薇,赵冬,刘静,孙佳艺,吴桂贤,曾哲淳,刘军,秦兰萍,吴兆苏.中国35~64岁人群血压水平与10年心血管病发病危险的前瞻性研究[J].中华内科杂志,2004,43(10):730-734. 被引量:147

二级参考文献67

共引文献320

同被引文献46

  • 1何伟,李英,胡志娟,牛凯,刘冰,宗毅,曹珍,郭岚.贝那普利对糖尿病大鼠肾脏的保护作用[J].河北医科大学学报,2005,26(3):182-185. 被引量:3
  • 2王先梅,杨丽霞,宋武战,齐峰,郭传明,石燕昆,赵颖,魏玲,王燕.盐酸贝那普利对自发性高血压大鼠肾脏纤维化的影响[J].第四军医大学学报,2006,27(20):1859-1862. 被引量:7
  • 3吴文,智喜梅,李东风,林凯,杨艳红.绝经后妇女骨质疏松患者血清IGF-1、IGFBP-3与骨密度及骨代谢指标的关系[J].中国病理生理杂志,2007,23(2):376-378. 被引量:16
  • 4Kuehn BM. Cardiovascular death risk linked to Azithromycin use[J].The Journal of the American Medical Association,2012,(6):2361.
  • 5Knirsch CA,Chandra R. Azithromycin and the risk of cardiovascular death[J].{H}The New England Journal of Medicine,2012,(6):772-775.
  • 6Liu Y.Cellular and molecular mechanisms of renal fibrosis[J].Nat Rev Nephrol,2011,7(12):684.
  • 7Du QH,Peng C,Zhang H.Polydatin:a review of pharmacology and pharmacokinetics[J].Pharm Biol,2013,51(11):1 347.
  • 8Chen L,Lan Z,Liu Q,et al.Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice[J].Food Chem Toxicol,2013,doi:10.1016/j.fct.2012.10.037.
  • 9Gao Y,Zeng Z,Li T,et al.Polydatin inhibits mitochondrial dysfunction in the renal tubular epithelial cells of a rat model of sepsis-induced acute kidney injury[J].Anesth Analg,2015,121(5):1 251.
  • 10Chevalier RL,Forbes MS,Thornhill BA.Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy[J].Kidney Int,2009,75(11):1 145.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部